Spain – Various medicinal products – suministro del medicamento SIRTURO 100 mg comprimido oral principio activo BEDAQUIL
Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria awarded €267K to JANSSEN CILAG, S.A. for Construction & Public Works in June 2024 — one of 94 awards this buyer has made, below its typical award size.
Winning supplier
JANSSEN CILAG, S.A.Contract description
Spain – Various medicinal products – suministro del medicamento SIRTURO 100 mg comprimido oral principio activo BEDAQUILINA, SPRAVATO 28 mg solución PULVERIZ NASAL principio activo ESKETAMINA, Y PONVORY 20 mg comprimido oral, principio activo PONESIMOD, con destino Servicio de Farmacia del Hospital Universitario Nuestra Señora de Candelaria
Related awards · Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria
94 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-354025-2025WERFEN ESPAÑA, S.A.U.€652K02 Jun 2025 Construction
- ocds-ted-696051-2024KERN PHARMA, S.L.€561K15 Nov 2024 Construction
- ocds-ted-693178-2024Roche Farma, S.A.€553K14 Nov 2024 Construction
Other wins · JANSSEN CILAG, S.A.
87 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-560856-2025OSAKIDETZA - Servicio Vasco de Salud - Organización Central€26.5M28 Aug 2025 Construction
- ocds-ted-288844-2024-1OSAKIDETZA - Servicio Vasco de Salud - Organización Central€19.3M16 May 2024 Construction
- ocds-ted-610065-2024OSAKIDETZA - Servicio Vasco de Salud - Organización Central€15.9M09 Oct 2024 Construction
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria and JANSSEN CILAG, S.A. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back